Judy Vong Email

VP, Head Regulatory Affairs . A2 Biotherapeutics

Current Roles

Employees:
167
Revenue:
$32.4M
About
A2 is dedicated to pushing the boundaries of science to transform medicine and turn the tide on cancer. We are focused on the next frontier in cell therapy: solid tumors. Our approach addresses the central problem of cancer research: tumor-targeted killing. We focus on targets either lost or gained in cancer cells, potentially creating breakthrough therapies to treat most cancers. The company was founded in 2018 by Alexander Kamb, Michael Gallo and Paul Kang and raised a Series A financing of $57 million (The Column Group, Vida Ventures, Samsara Capital and Nextech Invest).
A2 Biotherapeutics Address
30301 Agoura Road
Agoura Hills, null
A2 Biotherapeutics Email

Past Companies

A2 Biotherapeutics, Inc.Vice President, Head of Regulatory Affairs
A2 Biotherapeutics, IncSenior Director, Head of Regulatory Affairs
AmgenDirector, Global Regulatory Lead

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.